发明名称 |
Use of cyclodextrins to modulate gene expression with reducedimmunostimulatory response |
摘要 |
The present invention provides a method of reducing the immunostimulatory effects of certain phosphorothioate oligonucleotides used to treat pathogen-mediated disease states and other medical conditions. Immunostimulatory effects of phosphorothioate oligonucleotides are reduced in accordance with the method of the invention by administering the phosphorothioate oligonucleotide in a therapeutic formulation which includes at least one cyclodextrin to a mammal afflicted with the disease or condition being treated. The immune response of the mammal is also monitored in the method of the invention. |
申请公布号 |
AU6848596(A) |
申请公布日期 |
1997.04.01 |
申请号 |
AU19960068485 |
申请日期 |
1996.08.19 |
申请人 |
HYBRIDON, INC. |
发明人 |
QIUYAN ZHAO;JAMAL TEMSAMANI;SUDHIR AGRAWAL |
分类号 |
A61K47/40;A61K31/00;A61K47/48;A61K48/00;A61P37/00;A61P37/06 |
主分类号 |
A61K47/40 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|